|
|
Post by otherottawaguy on Mar 26, 2019 15:35:26 GMT -5
I have not found anything yet via Google and/or Health Canada drug listings, but am checking on a weekly basis.
If I am not mistaken I thought that we were supposed to hear something about a Canadian filing in the first quarter of 2019?
Anyone have a reference for this or am I just blowing smoke?
OOG
|
|
sky
Lab Rat
Posts: 46 
Sentiment: Long
|
Post by sky on Mar 26, 2019 15:52:51 GMT -5
I have not found anything yet via Google and/or Health Canada drug listings, but am checking on a weekly basis. If I am not mistaken I thought that we were supposed to hear something about a Canadian filing in the first quarter of 2019? Anyone have a reference for this or am I just blowing smoke? OOG I can only say Mnkd is not hitting on all cylinders.a lot of bs and smoke and mirrors the waiting game is getting old. |
|
|
|
Post by sportsrancho on Mar 26, 2019 16:38:58 GMT -5
I have not found anything yet via Google and/or Health Canada drug listings, but am checking on a weekly basis. If I am not mistaken I thought that we were supposed to hear something about a Canadian filing in the first quarter of 2019? Anyone have a reference for this or am I just blowing smoke? OOG Canada and Mexico. |
|
|
|
Post by sportsrancho on Mar 26, 2019 16:52:05 GMT -5
Here you go:
Zacks Small-Cap Research
PDFhttps://s1.q4cdn.com › files › News › Zac...
Dec 10, 2018 · MNKD s current market capitalization is underestimating the long-term ...... has regulatory filings for Afrezza in-progress in Mexico and Canada.
|
|
|
|
Post by sugarland on Mar 26, 2019 16:54:23 GMT -5
Here you go: Zacks Small-Cap Research PDFhttps://s1.q4cdn.com › files › News › Zac... Dec 10, 2018 · MNKD s current market capitalization is underestimating the long-term ...... has regulatory filings for Afrezza in-progress in Mexico and Canada. Oh Canada 🇨🇦. Say you say Aye-frezza? |
|
|
|
Post by dejude42 on Mar 27, 2019 5:15:17 GMT -5
|
|
|
|
Post by boca1girl on Mar 27, 2019 6:53:24 GMT -5
I have not found anything yet via Google and/or Health Canada drug listings, but am checking on a weekly basis. If I am not mistaken I thought that we were supposed to hear something about a Canadian filing in the first quarter of 2019? Anyone have a reference for this or am I just blowing smoke? OOG They are working on fillings in Canada and Mexico but I don’t remember any commitment or forecast on when approval maybe granted. We were told to expect approval for Brazil by year end 2018 and then 1Q (what I remember) but I don’t know what the current outlook is. |
|
|
|
Post by sportsrancho on Mar 30, 2019 12:48:18 GMT -5
According to Rose Alinaya, Mannkind’s senior vice president of investor relations and treasury, Afrezza is only approved in the U.S. but it’s looking to expand its horizons.
“We are currently working with collaboration partners to get Afrezza approved in Brazil and India,” she told dLife in an e-mail. “Additionally, regulatory filings are in progress for Mexico and Canada.”
In May of this year, Mannkind announced it entered into an exclusive marketing and distribution agreement with drug firm, Cipla for Afrezza in India.
|
|
|
|
Post by porkini on Mar 30, 2019 19:16:04 GMT -5
According to Rose Alinaya, Mannkind’s senior vice president of investor relations and treasury, Afrezza is only approved in the U.S. but it’s looking to expand its horizons. “We are currently working with collaboration partners to get Afrezza approved in Brazil and India,” she told dLife in an e-mail. “Additionally, regulatory filings are in progress for Mexico and Canada.” In May of this year, Mannkind announced it entered into an exclusive marketing and distribution agreement with drug firm, Cipla for Afrezza in India. So that would be year 2018 then since we are not to May 2019, right? (just clarifying, not harrasing)  |
|
|
|
Post by sportsrancho on Mar 30, 2019 19:45:06 GMT -5
According to Rose Alinaya, Mannkind’s senior vice president of investor relations and treasury, Afrezza is only approved in the U.S. but it’s looking to expand its horizons. “We are currently working with collaboration partners to get Afrezza approved in Brazil and India,” she told dLife in an e-mail. “Additionally, regulatory filings are in progress for Mexico and Canada.” In May of this year, Mannkind announced it entered into an exclusive marketing and distribution agreement with drug firm, Cipla for Afrezza in India. So that would be year 2018 then since we are not to May 2019, right? (just clarifying, not harrasing) Yes:-) I’m waiting with bated breath! Let’s get this show on the road. |
|
|
|
Post by mytakeonit on Mar 30, 2019 21:13:57 GMT -5
Fine. But, in Hawaii we eat a lot of sashimi ... so it would be "baited breath" !
|
|
